1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Poor-risk testicular cancer and high-dose chemotherapy
    Journal Article

    Motzer, R. J.; Sheinfeld, J.
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Overview of bladder cancer trials in the Cancer and Leukemia Group B
    Journal Article

    Small, E. J.; Halabi, S.; Dalbagni, G.; Pruthi, R.; Phillips, G.; Edelman, M.; Bajorin, D.
    Cancer (2003)

    Fulltext@MSK | Save
  • Prostate carcinoma: Defining therapeutic objectives and improving overall outcomes
    Journal Article

    Scher, H. I.
    Cancer (2003)

    Fulltext@MSK | Save
  • Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.
    Critical Reviews in Oncology/Hematology (2003)

    Fulltext@MSK | Save
  • Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center
    Journal Article

    Morris, M. J.; Scher, H. I.
    Critical Reviews in Oncology/Hematology (2003)

    Fulltext@MSK | Save
  • Cancerous and normal human tissues investigated by near-infrared time-resolved and spectroscopic imaging techniques
    Conference Paper

    Alrubaiee, M.; Gayen, S. K.; Koutcher, J. A.; Alfano, R. R.
    SPIE (2003)

    Fulltext@MSK | Save
  • DNA vaccines: An active immunization strategy for prostate cancer
    Journal Article

    Wolchok, J. D.; Gregor, P. D.; Nordquist, L. T.; Slovin, S. F.; Scher, H. I.
    Seminars in Oncology (2003)

    Fulltext@MSK | Save
  • Hsp90 as a therapeutic target in prostate cancer
    Journal Article

    Solit, D. B.; Scher, H. I.; Rosen, N.
    Seminars in Oncology (2003)

    Fulltext@MSK | Save
  • Prostate cancer: A dynamic illness with shifting targets
    Journal Article

    Shaffer, D. R.; Scher, H. I.
    Lancet Oncology (2003)

    Fulltext@MSK | Save
  • Management of recurrence and follow-up strategies for patients with seminoma and selected high-risk groups
    Journal Article

    Patel, M. I.; Motzer, R. J.; Sheinfeld, J.
    Urologic Clinics of North America (2003)

    Fulltext@MSK | Save